Cargando…
Management of skin rash during egfr-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendations
The epidermal growth factor receptor (egfr) is often overexpressed or dysregulated in a variety of solid tumours, including gastrointestinal (gi) malignancies. Agents targeting the egfr-mediated signalling pathway are increasingly part of the therapeutic armamentarium for the treatment of advanced l...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Multimed Inc.
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2644628/ https://www.ncbi.nlm.nih.gov/pubmed/19229368 |